Drug Information
| Drug General Information | |||||
|---|---|---|---|---|---|
| Drug ID |
D0B5AG
|
||||
| Former ID |
DNC009206
|
||||
| Drug Name |
Cis-3-phenoxy-2,3-dihydro-1H-inden-1-amine
|
||||
| Drug Type |
Small molecular drug
|
||||
| Indication | Discovery agent | Investigative | [529530] | ||
| Structure |
|
Download2D MOL |
|||
| Formula |
C15H15NO
|
||||
| Canonical SMILES |
C1C(C2=CC=CC=C2C1OC3=CC=CC=C3)N
|
||||
| InChI |
1S/C15H15NO/c16-14-10-15(13-9-5-4-8-12(13)14)17-11-6-2-1-3-7-11/h1-9,14-15H,10,16H2/t14-,15+/m1/s1
|
||||
| InChIKey |
AFPFOKAYUJMERG-CABCVRRESA-N
|
||||
| PubChem Compound ID | |||||
| Target and Pathway | |||||
| Target(s) | Sodium-dependent noradrenaline transporter | Target Info | Inhibitor | [529530] | |
| Sodium-dependent dopamine transporter | Target Info | Inhibitor | [529530] | ||
| Pathway Interaction Database | Alpha-synuclein signaling | ||||
| WikiPathways | Monoamine Transport | ||||
| NRF2 pathway | |||||
| Transport of glucose and other sugars, bile salts and organic acids, metal ions and amine compoundsWP727:Monoamine Transport | |||||
| Dopaminergic Neurogenesis | |||||
| Parkinsons Disease Pathway | |||||
| Transport of glucose and other sugars, bile salts and organic acids, metal ions and amine compounds | |||||
| Neurotransmitter Clearance In The Synaptic Cleft | |||||
| References | |||||
If You Find Any Error in Data or Bug in Web Service, Please Kindly Report It to Dr. Zhou and Dr. Zhang.